[ad_1]
Eli Lilly shares rose 3% in pre-sale on Tuesday after the pharmaceutical company overtook second-quarter estimates and announced that it would file a first public offering for its unit of animal health.
Source link
[ad_1]
Eli Lilly shares rose 3% in pre-sale on Tuesday after the pharmaceutical company overtook second-quarter estimates and announced that it would file a first public offering for its unit of animal health.
Source link
